• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨密度测定和生化指标评估海洋性贫血症的骨病。

Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices.

机构信息

Department of Pediatrics, Dr Balabhai Nanavati hospital Mumbai, 501, Rangmahal 5th floor, 2 Mount Mary road, Bandra (West), Mumbai 400050, India.

出版信息

Indian J Pediatr. 2010 Sep;77(9):987-91. doi: 10.1007/s12098-010-0158-2. Epub 2010 Aug 25.

DOI:10.1007/s12098-010-0158-2
PMID:20737251
Abstract

OBJECTIVE

To evaluate osteopathy in thalassemia by bone mineral densitometry (BMD) and biochemical indices.

METHODS

Prospective review analysis with no follow up from 2006 to 2007 of 42 regularly transfused thalassemics aged 10-25 years (27 boys, 15 girls) was done. Anthropometry, pubertal stage and symptomatology were noted. Urinary C-terminal cross-linked telopeptide of type-1 collagen (Crosslaps) by ELISA; serum 25-OH vitamin D and osteocalcin by RIA; parathyroid hormone (PTH) and ferritin by chemiluminescence and IGF-1 by Enzyme immunoassay were evaluated. Dual Energy X-ray Absorptiometry (DEXA) of lumbar spine and femur was done on Lunar prodigy system. Data was entered and analyzed using the SPSS for Windows software. Mean comparisons were done by ANOVA 1 and data was compared using Chi-square test and p value < 0.05 was taken as significant.

RESULTS

Of 42 patients, 81% had osteoporosis by Z-score of DEXA. Urinary crosslaps was high in 55%; 36% had increased osteocalcin; 62% had low vitamin D levels; 38% had high parathyroid levels and IGF-1 was low in 52%. Mean serum ferritin level was 5344 ± 2855 ng/dl. There was statistical significance (p = 0.046) between chronological age and BMD. All 42 cases were divided into two groups: Group-1 (Normal DEXA), Group-2 (Abnormal DEXA) and analysis of biochemical indices between two groups showed no significant difference in any of the biochemical parameters.

CONCLUSION

This study revealed majority of thalassemics with inadequate chelation have bone resorption with advancing chronological age and BMD should be evaluated regularly for early diagnosis to prevent morbidity.

摘要

目的

通过骨矿物质密度(BMD)和生化指标评估地中海贫血症患者的骨密度。

方法

2006 年至 2007 年,对 42 名年龄在 10-25 岁(27 名男孩,15 名女孩)的定期输血地中海贫血症患者进行了前瞻性回顾性分析,无随访。记录人体测量学、青春期阶段和症状。通过 ELISA 检测尿 1 型胶原 C 端交联肽(Crosslaps);用 RIA 检测血清 25-羟维生素 D 和骨钙素;用化学发光法检测甲状旁腺激素(PTH)和铁蛋白;用酶联免疫吸附试验检测 IGF-1。在 Lunar prodigy 系统上进行腰椎和股骨的双能 X 射线吸收法(DEXA)。使用 Windows 软件的 SPSS 软件输入和分析数据。通过方差分析 1 进行均值比较,并通过卡方检验比较数据,p 值<0.05 视为显著。

结果

42 例患者中,81%的患者通过 DEXA 的 Z 评分患有骨质疏松症。55%的患者尿 Crosslaps 升高;36%的患者骨钙素升高;62%的患者维生素 D 水平低;38%的患者甲状旁腺水平高,52%的患者 IGF-1 水平低。血清铁蛋白平均水平为 5344±2855ng/dl。年龄与 BMD 之间存在统计学意义(p=0.046)。将 42 例患者分为两组:组 1(DEXA 正常)和组 2(DEXA 异常),对两组生化指标进行分析,两组之间的生化参数均无显著差异。

结论

本研究显示,大多数铁螯合不足的地中海贫血症患者有骨吸收,随着年龄的增长,BMD 应定期评估,以便早期诊断,预防发病。

相似文献

1
Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices.骨密度测定和生化指标评估海洋性贫血症的骨病。
Indian J Pediatr. 2010 Sep;77(9):987-91. doi: 10.1007/s12098-010-0158-2. Epub 2010 Aug 25.
2
Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: a comparison study.采用双能X线吸收法和定量计算机断层扫描评估重型β地中海贫血患者的腰椎骨密度:一项比较研究。
J Pediatr Hematol Oncol. 2006 Feb;28(2):73-8. doi: 10.1097/01.mph.0000199587.76055.21.
3
[Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].[体质性生长和青春期延迟男孩的骨密度及骨代谢相关指标评估]
Ann Acad Med Stetin. 2000;46:165-76.
4
Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.成年地中海贫血患者的骨转换与骨密度:与生长激素分泌状态及循环生长调节素的关系
Endocrine. 2016 Aug;53(2):551-7. doi: 10.1007/s12020-016-0865-1. Epub 2016 Jan 29.
5
Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India.印度北部地中海贫血患者25-羟维生素D缺乏状况及维生素D受体基因多态性对骨密度的影响
Hematology. 2012 Sep;17(5):291-6. doi: 10.1179/1607845412Y.0000000017.
6
Bone mineral density and metabolism in familial dysautonomia.家族性自主神经功能异常中的骨矿物质密度与代谢
Osteoporos Int. 2002 May;13(5):429-33. doi: 10.1007/s001980200050.
7
Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.布鲁克林一个极端正统犹太社区青少年的脊柱骨密度降低。
Pediatrics. 2001 May;107(5):E79. doi: 10.1542/peds.107.5.e79.
8
Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.接受原位肝移植的肝硬化患者的骨质疏松症和骨矿物质代谢紊乱
Calcif Tissue Int. 1997 Feb;60(2):148-54. doi: 10.1007/s002239900205.
9
Low bone mineral density and vitamin d deficiency correlated with genetics and other bone markers in female Turkish immigrants in Germany.在德国的土耳其女性移民中,低骨矿物质密度和维生素D缺乏与遗传因素及其他骨标志物相关。
Clin Rheumatol. 2016 Nov;35(11):2789-2795. doi: 10.1007/s10067-016-3237-6. Epub 2016 Mar 31.
10
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women.胰岛素样生长因子-1 与健康绝经前妇女的骨形成标志物、PTH 和骨密度相关。
Bone. 2010 Jan;46(1):244-7. doi: 10.1016/j.bone.2009.10.011. Epub 2009 Oct 21.

引用本文的文献

1
Bone and Joint Involvement in Beta Thalassemic Patients: A Cross-sectional Study.β地中海贫血患者的骨骼和关节受累情况:一项横断面研究。
Indian J Orthop. 2024 Nov 5;59(1):69-76. doi: 10.1007/s43465-024-01225-0. eCollection 2025 Jan.
2
Bone Mineral Density, Serum Calcium, and Vitamin D Levels in Adult Thalassemia Major Patients: Experience From a Single Center in Eastern India.成年重型地中海贫血患者的骨矿物质密度、血清钙和维生素D水平:来自印度东部一个单一中心的经验
Cureus. 2022 Jul 9;14(7):e26688. doi: 10.7759/cureus.26688. eCollection 2022 Jul.
3
Correlation of Transferrin Saturation and Serum Ferritin with Bone Mass Density in Adult Transfusion Dependent Beta-Thalassemia Patients.

本文引用的文献

1
Bone mineral density in beta-thalassemia major and intermedia.重型和中间型β地中海贫血的骨矿物质密度
Indian Pediatr. 2007 Jan;44(1):29-32.
2
Osteoporosis in beta-thalassemia: Clinical and genetic aspects.β地中海贫血中的骨质疏松症:临床与遗传学方面
Ann N Y Acad Sci. 2005;1054:451-6. doi: 10.1196/annals.1345.051.
3
Bone mineral density in beta - thalassemic Lebanese children.
J Musculoskelet Neuronal Interact. 2002 Sep;2(5):463-8.
成人依赖输血的β地中海贫血患者转铁蛋白饱和度和血清铁蛋白与骨密度的相关性
J Blood Med. 2021 Sep 9;12:827-832. doi: 10.2147/JBM.S328547. eCollection 2021.
4
Vitamin D and bone health status in beta thalassemia patients-systematic review.维生素 D 与β地中海贫血患者的骨骼健康状况:系统评价。
Osteoporos Int. 2021 Jun;32(6):1031-1040. doi: 10.1007/s00198-021-05821-w. Epub 2021 Jan 9.
5
Zoledronic Acid for Treatment of Low Bone Mineral Density in Patients with Beta Thalassemia Major.唑来膦酸治疗重型β地中海贫血患者低骨密度
Indian J Hematol Blood Transfus. 2018 Oct;34(4):648-652. doi: 10.1007/s12288-018-0953-x. Epub 2018 Mar 27.
6
Intestinal calcium transport and its regulation in thalassemia: interaction between calcium and iron metabolism.地中海贫血中肠道钙转运及其调节:钙与铁代谢之间的相互作用
J Physiol Sci. 2018 May;68(3):221-232. doi: 10.1007/s12576-018-0600-1. Epub 2018 Feb 26.
7
Fractures and Low Bone Mineral Density in Patients with Beta Thalassemia Major.重型β地中海贫血患者的骨折与低骨矿物质密度
Indian J Hematol Blood Transfus. 2018 Jan;34(1):163-165. doi: 10.1007/s12288-017-0820-1. Epub 2017 Apr 22.
8
Comparison of Bone Mineral Density in Thalassemia Major Patients with Healthy Controls.重型地中海贫血患者与健康对照者骨密度的比较。
Adv Hematol. 2015;2015:648349. doi: 10.1155/2015/648349. Epub 2015 Dec 31.
9
Molecular Aspects of Bone Resorption in β-Thalassemia Major.β-地中海贫血中骨质吸收的分子机制。
Cell J. 2015 Summer;17(2):193-200. doi: 10.22074/cellj.2016.3713. Epub 2015 Jul 11.
10
Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents.儿童和青少年输血依赖型β地中海贫血的骨骼相关并发症。
J Bone Miner Metab. 2013 Jul;31(4):468-76. doi: 10.1007/s00774-013-0433-1. Epub 2013 Mar 10.
4
New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.β地中海贫血患者骨质疏松症的病理生理学与管理新见解
Br J Haematol. 2004 Oct;127(2):127-39. doi: 10.1111/j.1365-2141.2004.05143.x.
5
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle.骨保护素和核因子κB受体活化因子配体在 thalassemia 诱导的骨质疏松症发病机制中的作用:谜题的新线索。
J Bone Miner Res. 2004 May;19(5):722-7. doi: 10.1359/JBMR.040113. Epub 2004 Jan 12.
6
Serum zinc and its relation to bone mineral density in beta-thalassemic adolescents.
Biol Trace Elem Res. 2004 Mar;97(3):215-24. doi: 10.1385/bter:97:3:215.
7
Abnormalities in bone mineral density and bone histology in thalassemia.地中海贫血患者的骨矿物质密度和骨组织学异常。
J Bone Miner Res. 2003 Sep;18(9):1682-8. doi: 10.1359/jbmr.2003.18.9.1682.
8
Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia.
J Clin Endocrinol Metab. 2003 Aug;88(8):3966-72. doi: 10.1210/jc.2002-021548.
9
Effects of thalassemia major on bone mineral density in late adolescence.重型地中海贫血对青春期晚期骨矿物质密度的影响。
J Pediatr Endocrinol Metab. 2003 Mar;16 Suppl 2:337-42.
10
Bone resorption is increased in young adults with thalassaemia major.重型地中海贫血的年轻成年人骨吸收增加。
Br J Haematol. 2001 Jan;112(1):36-41. doi: 10.1046/j.1365-2141.2001.02549.x.